Edition:
India

AngioDynamics Inc (ANGO.OQ)

ANGO.OQ on NASDAQ Stock Exchange Global Select Market

17.03USD
8 Dec 2017
Change (% chg)

$-0.01 (-0.06%)
Prev Close
$17.04
Open
$17.14
Day's High
$17.14
Day's Low
$16.94
Volume
49,780
Avg. Vol
75,465
52-wk High
$18.83
52-wk Low
$14.81

Latest Key Developments (Source: Significant Developments)

AngioDynamics reports fiscal 2017 first quarter results
Wednesday, 5 Oct 2016 

AngioDynamics Inc : AngioDynamics reports fiscal 2017 first quarter results . Q1 adjusted non-GAAP earnings per share $0.17 . Q1 sales $88.1 million versus I/B/E/S view $86 million . Q1 earnings per share $0.04 . Q1 earnings per share view $0.13 -- Thomson Reuters I/B/E/S . Sees FY 2017 adjusted earnings per share $0.62 to $0.65 . FY2017 guidance remains unchanged . FY2017 earnings per share view $0.63, revenue view $358.6 million -- Thomson Reuters I/B/E/S .Sees FY 2017 sales $355 million to $360 million.  Full Article

AngioDynamics names Michael Greiner as new CFO
Monday, 25 Jul 2016 

AngioDynamics Inc : AngioDynamics appoints Michael C. Greiner as new chief financial officer .Greiner most recently served as chief financial officer at extreme reach.  Full Article

Intouch Health appoints Joseph Devivo as new CEO
Tuesday, 19 Jul 2016 

Intouch Health: Says Intouch Health announces new CEO . Intouch Health says appointed Joseph M. Devivo as its new chief executive officer .Says Devivo was most recently President, CEO and Director Of AngioDynamics.  Full Article

Angiodynamics reports Q4 loss $1.21/shr
Wednesday, 13 Jul 2016 

Angiodynamics Inc : Angiodynamics reports fiscal 2016 fourth quarter and full year results . Sees Q1 adjusted shr $0.11 to $0.14 . Q4 shr loss $1.21 . Sees Q1 sales $84 mln to $87 mln . Q4 sales $93.4 mln vs I/B/E/S view $88.4 mln . Q4 shr view $0.16 -- thomson reuters I/B/E/S . Sees FY 2017 adjusted shr $0.62 to $0.65 . Q4 adjusted non-GAAP shr $0.19 excluding items . Sees FY 2017 sales $355 mln to $360 mln . Sees FY2017 free cash flow guidance of greater than $30 mln . FY2017 shr view $0.66, rev view $358.6 mln -- Thomson Reuters I/B/E/S .Q1 shr view $0.14, rev view $86.4 mln -- Thomson Reuters I/B/E/S.  Full Article

AngioDynamics Inc lowers FY 2016 guidance; gives Q3 2016 guidance below analysts' estimates
Friday, 8 Jan 2016 

AngioDynamics Inc:Revised FY 2016 net sales guidance to $353 to $359 million and adjusted earnings per share (EPS) of $0.59 to $0.63.expects Q3 2016 net sales to be in the range of $84 to $87 million and adjusted EPS of $0.10 to $0.14.Q3 2016 revenue of $92 million and EPS of $0.17 - Thomson Reuters I/B/E/S.FY 2016 revenue of $363 million and EPS of $0.62 - Thomson Reuters I/B/E/S.  Full Article